SLAMF8 Recombinant Rabbit mAb (S-1956-78),Starter_specification/price/image

Product Detail
Company Profile

Product Specification

Host	Rabbit
Antigen	SLAMF8
Synonyms	SLAM family member 8; B-lymphocyte activator macrophage expressed; BCM-like membrane protein; CD353; BLAME
Immunogen	Synthetic Peptide
Location	Membrane
Accession	Q9P0V8
Clone Number	S-1956-78
Antibody Type	Recombinant mAb
Isotype	IgG
Application	WB
Reactivity	Ms, Rt
Positive Sample	mouse lung, mouse thymus, mouse spleen, rat lung, rat thymus, rat spleen
Purification	Protein A
Concentration	0.5 mg/ml
Conjugation	Unconjugated
Physical Appearance	Liquid
Storage Buffer	PBS, 40% Glycerol, 0.05% BSA, 0.03% Proclin 300
Stability & Storage	12 months from date of receipt / reconstitution, -20 掳C as supplied

Dilution

application	dilution	species
WB	1:1000	Ms, Rt

Background

SLAMF8, also known as B-lymphocyte activator macrophage expressed (BLAME) or CD353, is a single-pass type I membrane protein belonging to the SLAM (Signaling Lymphocyte Activation Molecule) family. It is characterized by the presence of Ig-like domains and is primarily expressed in immune-related tissues such as the lymph node, spleen, and thymus. SLAMF8 has been identified as a potential new immune checkpoint molecule, with its high expression associated with poor prognosis in colorectal cancer. This protein is involved in immune regulation and may play a role in various immune responses, including those related to inflammation and autoimmune diseases.

AntBio is a biotechnology group company dedicated to serving life sciences, aiming to help scientists accelerate research and improve work efficiency. AntBio provides comprehensive and high-quality reagent tools for basic research, drug development, and diagnosis, including research grade antibodies, proteins, biochemical reagents, and assay kits. These research tools are widely used in different segments of life science research. The group company currently consists of three brands, Absin, Starter-Bio and UA-Bio.